This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Askbio Inc., Asklepios Biopharmaceutical, Inc., Synpromics Ltd.. Active years: 2025-2026.
Company Filing History:
1 out of 6 
1 out of 12 
1 out of 2 Years Active: 2025-2026
Title: Ross Fraser: Innovator in Nucleic Acid Enrichment
Introduction
Ross Fraser is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid enrichment. His innovative methods have the potential to advance research and applications in genetics and biotechnology.
Latest Patents
Fraser holds a patent for "Methods and compositions for enriching nucleic acids." This invention relates to methods of enriching target single-stranded nucleic acids in a mixed population of single-stranded nucleic acids. The method involves protecting the target single-stranded nucleic acids and using a 5' exonuclease to digest the non-target single-stranded nucleic acids. Additionally, the invention includes methods of cloning target single-stranded nucleic acids into vectors, along with associated compositions and kits. He has 1 patent to his name.
Career Highlights
Throughout his career, Ross Fraser has worked with prominent companies in the biotechnology sector. Notable among these are Asklepios Biopharmaceutical, Inc. and Synpromics Ltd. His work in these organizations has contributed to advancements in biopharmaceuticals and genetic research.
Collaborations
Fraser has collaborated with esteemed colleagues, including Anne Braae and Juan Manuel Iglesias Gonzalez. These partnerships have fostered innovation and development in their respective fields.
Conclusion
Ross Fraser's contributions to nucleic acid enrichment demonstrate his commitment to advancing scientific knowledge and technology. His innovative methods and collaborations highlight the importance of teamwork in achieving breakthroughs in biotechnology.